| Literature DB >> 33332396 |
Xiaoyuan Li1,2,3, Hongyu Si2,3, Yamin Chen1, Shouhao Li1, Ningning Yin2, Zhenlong Wang4.
Abstract
Currently, qigong and tai chi exercises are the two most common preventive as well as therapeutic interventions for chronic metabolic diseases such as type 2 diabetes mellitus (T2DM). However, the quantitative evaluation of these interventions is limited. This study aimed to evaluate the therapeutic efficacy of qigong and tai chi intervention in middle-aged and older adults with T2DM. The study included 103 eligible participants, who were randomized to participate for 12 weeks, in one of the following intervention groups for the treatment of T2DM: fitness qigong, tai chi, and control group. Three biochemical measures, including fasting plasma glucose (FPG), glycated hemoglobin (HbA1C), and C-peptide (C-P) levels, assessed at baseline and 12 weeks, served as the primary outcome measures. During the training process, 16 of the 103 participants dropped out. After the 12-week intervention, there were significant influences on HbA1C (F2,83 = 4.88, p = 0.010) and C-P levels (F2,83 = 3.64, p = 0.031). Moreover, significant reduction in C-P levels was observed after 12-week tai chi practice (p = 0.004). Furthermore, there was a significant negative correlation between the duration of T2DM and the relative changes in FPG levels after qigong intervention, and the relative changes in HbA1C levels were positively correlated with waist-to-height ratio after tai chi practice. Our study suggests that targeted qigong exercise might have a better interventional effect on patients with a longer duration of T2DM, while tai chi might be risky for people with central obesity. Trial registration: This trial was registered in Chinese Clinical Trial Registry. The registration number is ChiCTR180020069. The public title is "Health-care qigong · study for the prescription of chronic diabetes intervention."Entities:
Mesh:
Substances:
Year: 2020 PMID: 33332396 PMCID: PMC7746158 DOI: 10.1371/journal.pone.0243989
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Screening, randomization, and completion of the 12-week intervention.
Baseline characteristics of the study participants.
| Variables | Qigong ( | Tai Chi ( | Control ( |
|---|---|---|---|
| Demographic | |||
| Male sex, % | 21 (62) | 12 (50) | 14 (48) |
| Age, | 59.71 ± 6.67 | 61.71 ± 6.91 | 58.66 ± 10.89 |
| BMI | 25.21 ± 2.71 | 24.04 ± 2.98 | 25.69 ± 2.57 |
| WHtR | 0.53 ± 0.05 | 0.52 ± 0.05 | 0.53 ± 0.05 |
| Duration of T2DM, | 9.00 ± 6.39 | 9.08 ± 5.93 | 7.42 ± 5.49 |
| Medications (%) | |||
| None | 8 (24) | 6 (25) | 13 (45) |
| Diaformin tablets | 7 (21) | 3 (13) | 8 (28) |
| Insulin | 6 (18) | 5 (21) | 4 (14) |
| Drug combination | 6 (18) | 6 (25) | 4 (14) |
| Chinese medicine | 2 (6) | 1 (4) | 0 (0) |
| Glimepiride tablets | 3 (9) | 1 (4) | 0 (0) |
| Glipizide tablets | 7 (21) | 3 (13) | 8 (28) |
| Biochemical measures | |||
| FPG | 8.78 ± 3.46 | 8.72 ± 2.79 | 6.83 ± 2.80 |
| HbA1C | 7.99 ± 1.66 | 8.20 ± 2.46 | 7.63 ± 1.74 |
| C-P | 1.60 ± 0.81 | 1.37 ± 0.43 | 1.62 ± 1.16 |
Values are presented as n (%) or mean ± standard deviation.
BMI is the weight in kilograms divided by the height squared in meters.
WHtR is the waist circumference in centimeters divided by the height in centimeters.
FPG is the amount of glucose present in the blood of humans and other animals before meals [29]. It is recommended in the guidelines published by the American Diabetes Association as the preferred test for diagnosing diabetes, and the lower limit for impaired fasting glucose was reduced from an FPG level of 6.1 to 5.6 mmol/L [45].
HbA1C, which reflects the average plasma glucose concentration over 2–3 months, is weighted toward more recent levels and is useful for monitoring glycemic control in diabetic patients [46].
C-P level is used for assessing a person’s natural insulin secretion and is used for distinguishing type 1 DM from T2DM or maturity-onset diabetes of the young [47].
BMI, body mass index; WHtR, waist-to-height ratio; T2DM, type 2 diabetes mellitus; FPG, fasting plasma glucose; HbA1C, glycated hemoglobin; C-P, C-peptide levels.
Fig 2The effects of interventions on FPG (A), HbA1C (B), and C-P levels (C). FPG, fasting plasma glucose; HbA1C, glycated hemoglobin; C-P, C-peptide levels; LSD, least-significant difference; ANCOVA, analysis of covariance.
Fig 3Relationship between the relative changes in the three biochemical parameters (FPG, HbA1C, and C-P level) and age (years(y)) in the control, qigong, and tai chi intervention groups for 12 weeks.
FPG: fasting plasma glucose; HbA1C: glycated hemoglobin; C-P: C-peptide levels.
Fig 6Relationship between the relative changes in the three biochemical parameters (FPG, HbA1C, and C-P level) and WHtR in the control, qigong, and tai chi intervention groups for 12 weeks.
FPG: fasting plasma glucose; HbA1C: glycated hemoglobin; C-P: C-peptide levels; WHtR: waist-to-height ratio; R: correlation coefficient.
Fig 4Relationship between the relative changes in the three biochemical parameters (FPG, HbA1C, and C-P level) and duration of DM (years (y)) in the control, qigong, and tai chi intervention groups for 12 weeks.
FPG: fasting plasma glucose; HbA1C: glycated hemoglobin; C-P: C-peptide levels; R: Correlation coefficient; DM: diabetes mellitus.